200 related articles for article (PubMed ID: 15577645)
1. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
Caron M; Auclair M; Lagathu C; Lombès A; Walker UA; Kornprobst M; Capeau J
AIDS; 2004 Nov; 18(16):2127-36. PubMed ID: 15577645
[TBL] [Abstract][Full Text] [Related]
2. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors.
Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM;
Antivir Ther; 2007; 12(2):205-16. PubMed ID: 17503663
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
[TBL] [Abstract][Full Text] [Related]
4. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
[TBL] [Abstract][Full Text] [Related]
5. Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes.
Janneh O; Hoggard PG; Tjia JF; Jones SP; Khoo SH; Maher B; Back DJ; Pirmohamed M
Antivir Ther; 2003 Oct; 8(5):417-26. PubMed ID: 14640389
[TBL] [Abstract][Full Text] [Related]
6. Thymidine analogues suppress autophagy and adipogenesis in cultured adipocytes.
Stankov MV; Panayotova-Dimitrova D; Leverkus M; Schmidt RE; Behrens GM
Antimicrob Agents Chemother; 2013 Jan; 57(1):543-51. PubMed ID: 23147731
[TBL] [Abstract][Full Text] [Related]
7. Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase.
Bradshaw D; Malik S; Booth C; Van Houtte M; Pattery T; Waters A; Ainsworth J; Geretti AM
Antimicrob Agents Chemother; 2007 Dec; 51(12):4489-91. PubMed ID: 17876005
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.
Hill SA; Lloyd PA; McDonald S; Wykoff J; Derse D
J Infect Dis; 2003 Aug; 188(3):424-7. PubMed ID: 12870124
[TBL] [Abstract][Full Text] [Related]
9. Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.
Stankov MV; Schmidt RE; Behrens GM;
Antimicrob Agents Chemother; 2008 Aug; 52(8):2882-9. PubMed ID: 18474584
[TBL] [Abstract][Full Text] [Related]
10. Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues.
Caron M; Auclairt M; Vissian A; Vigouroux C; Capeau J
Antivir Ther; 2008; 13(1):27-38. PubMed ID: 18389896
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.
Cihlar T; Birkus G; Greenwalt DE; Hitchcock MJ
Antiviral Res; 2002 Apr; 54(1):37-45. PubMed ID: 11888656
[TBL] [Abstract][Full Text] [Related]
12. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
Jones SP; Janneh O; Back DJ; Pirmohamed M
Antivir Ther; 2005; 10(2):207-13. PubMed ID: 15865214
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of C-reactive protein and stavudine on adipogenesis.
Stankov MV; Schmidt RE; Behrens GM
Antivir Ther; 2009; 14(6):819-29. PubMed ID: 19812444
[TBL] [Abstract][Full Text] [Related]
14. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions.
Walker UA; Auclair M; Lebrecht D; Kornprobst M; Capeau J; Caron M
Antivir Ther; 2006; 11(1):25-34. PubMed ID: 16518957
[TBL] [Abstract][Full Text] [Related]
15. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.
McComsey GA; Paulsen DM; Lonergan JT; Hessenthaler SM; Hoppel CL; Williams VC; Fisher RL; Cherry CL; White-Owen C; Thompson KA; Ross ST; Hernandez JE; Ross LL
AIDS; 2005 Jan; 19(1):15-23. PubMed ID: 15627029
[TBL] [Abstract][Full Text] [Related]
16. Reverse transcriptase inhibitors alter uncoupling protein-1 and mitochondrial biogenesis in brown adipocytes.
Rodríguez de la Concepción ML; Yubero P; Domingo JC; Iglesias R; Domingo P; Villarroya F; Giralt M
Antivir Ther; 2005; 10(4):515-26. PubMed ID: 16038477
[TBL] [Abstract][Full Text] [Related]
17. In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1.
Margot NA; Miller MD
Antivir Ther; 2005; 10(2):343-8. PubMed ID: 15865229
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
Geleziunas R; Gallagher K; Zhang H; Bacheler L; Garber S; Wu JT; Shi G; Otto MJ; Schinazi RF; Erickson-Viitanen S
Antivir Chem Chemother; 2003 Jan; 14(1):49-59. PubMed ID: 12790516
[TBL] [Abstract][Full Text] [Related]
19. [Tenofovir as a strategy to avoid or limit adverse effects].
Portilla J
Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():19-24. PubMed ID: 19195434
[TBL] [Abstract][Full Text] [Related]
20. Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.
Picard V; Angelini E; Maillard A; Race E; Clavel F; Chêne G; Ferchal F; Molina JM
J Infect Dis; 2001 Sep; 184(6):781-4. PubMed ID: 11517441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
